Endocrinology, Vol 129, 1596-1604, Copyright © 1991 by Endocrine Society

ARTICLES

Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix

G van der Pluijm, W Most, L van der Wee-Pals, H de Groot, S Papapoulos and C Lowik
Department of Endocrinology and Metabolic Diseases, University Hospital, Leiden, The Netherlands.

The multifunctional cytokine tumor necrosis factor-alpha (TNF alpha) stimulates osteoclastic resorption. It is not known which steps in osteoclast formation are affected by TNF alpha. We have investigated the effects of recombinant human TNF alpha (rhTNF alpha) on osteoclast development and osteoclastic resorption in two different in vitro resorption systems which are each characterized by a different stage of development of the osteoclast. The effects were further compared to those of bovine PTH-(1-84). rhTNF alpha at concentrations between 0.01- 50 ng/ml (3 x 10(-13) to 1.5 x 10(-9) M) did not alter the activity of mature osteoclasts, measured as 45Ca release in fetal mouse radii. In the osteoclast precursor-dependent system (fetal mouse metacarpals) rhTNF alpha had a biphasic effect. It stimulated resorption dose- dependently from 0.01 ng/ml onward, with a maximal response at 0.5 ng/ml. At concentrations above 10 ng/ml rhTNF alpha, resorption was inhibited. In experiments in which irradiation was used to block replication, it was found that TNF alpha stimulates the proliferation of osteoclast progenitors at both low and high concentrations. As a result, at relatively low concentrations, more osteoclasts were formed in the calcified matrix, coinciding with an increased release of 45Ca. However, at relatively high concentrations, the increase in osteoclast progenitors did not lead to increased resorption, since the putative osteoclast progenitors were arrested in the periosteum. In comparison, bovine PTH-(1-84) stimulated resorption independent of proliferation by enhancing the differentiation of postmitotic osteoclast precursors and activating mature osteoclasts. In conclusion, the effects of TNF alpha on osteoclastic resorption are dependent on the stage of osteoclast development and the concentrations applied.

This article has been cited by other articles:

				H. Shimizu, H. Nakagami, M. K. Osako, R. Hanayama, Y. Kunugiza, T. Kizawa, T. Tomita, H. Yoshikawa, T. Ogihara, and R. Morishita Angiotensin II accelerates osteoporosis by activating osteoclasts FASEB J, July 1, 2008; 22(7): 2465 - 2475. [Abstract] [Full Text] [PDF]

				S. D. Yogesha, S. M. Khapli, and M. R. Wani Interleukin-3 and Granulocyte-Macrophage Colony-stimulating Factor Inhibits Tumor Necrosis Factor (TNF)-{alpha}-induced Osteoclast Differentiation by Down-regulation of Expression of TNF Receptors 1 and 2 J. Biol. Chem., March 25, 2005; 280(12): 11759 - 11769. [Abstract] [Full Text] [PDF]

				J. L. Gonzalez-Calvin, F. Gallego-Rojo, R. Fernandez-Perez, F. Casado-Caballero, E. Ruiz-Escolano, and E. G. Olivares Osteoporosis, Mineral Metabolism, and Serum Soluble Tumor Necrosis Factor Receptor p55 in Viral Cirrhosis J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4325 - 4330. [Abstract] [Full Text] [PDF]

				Z. Zhang, E. Jimi, and A. L. M. Bothwell Receptor Activator of NF-{kappa}B Ligand Stimulates Recruitment of SHP-1 to the Complex Containing TNFR-Associated Factor 6 That Regulates Osteoclastogenesis J. Immunol., October 1, 2003; 171(7): 3620 - 3626. [Abstract] [Full Text] [PDF]

				G. van der Pluijm, M. Deckers, B. Sijmons, H. de Groot, J. Bird, R. Wills, S. Papapoulos, A. Baxter, and C. Lowik In Vitro and in Vivo Endochondral Bone Formation Models Allow Identification of Anti-Angiogenic Compounds Am. J. Pathol., July 1, 2003; 163(1): 157 - 163. [Abstract] [Full Text] [PDF]

				Md. M. Rahman, A. Kukita, T. Kukita, T. Shobuike, T. Nakamura, and O. Kohashi Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages Blood, May 1, 2003; 101(9): 3451 - 3459. [Abstract] [Full Text] [PDF]

				K. Fuller, C. Murphy, B. Kirstein, S. W. Fox, and T. J. Chambers TNF{alpha} Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL Endocrinology, March 1, 2002; 143(3): 1108 - 1118. [Abstract] [Full Text] [PDF]

				J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]

				G.-Q. Yao, B.-h. Sun, K. L. Insogna, and E. C. Weir Nuclear Factor-{kappa}B p50 Is Required for Tumor Necrosis Factor-{alpha}-Induced Colony-Stimulating Factor-1 Gene Expression in Osteoblasts Endocrinology, August 1, 2000; 141(8): 2914 - 2922. [Abstract] [Full Text] [PDF]

				Y. Azuma, K. Kaji, R. Katogi, S. Takeshita, and A. Kudo Tumor Necrosis Factor-alpha Induces Differentiation of and Bone Resorption by Osteoclasts J. Biol. Chem., February 18, 2000; 275(7): 4858 - 4864. [Abstract] [Full Text] [PDF]

				P. A. Hill, A. Tumber, S. Papaioannou, and M. C. Meikle The Cellular Actions of Interleukin-11 on Bone Resorption in Vitro Endocrinology, April 1, 1998; 139(4): 1564 - 1572. [Abstract] [Full Text] [PDF]

				R. B. Kimble, S. Srivastava, F. P. Ross, A. Matayoshi, and R. Pacifici Estrogen Deficiency Increases the Ability of Stromal Cells to Support Murine Osteoclastogenesis via an Interleukin-1and Tumor Necrosis Factor-mediated Stimulation of Macrophage Colony-stimulating Factor Production J. Biol. Chem., November 15, 1996; 271(46): 28890 - 28897. [Abstract] [Full Text] [PDF]